Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Submissions extended for the Misuse of Drugs (Pseudoephedrine) Amendment Bill 2024
Submissions extended for the Misuse of Drugs (Pseudoephedrine) Amendment Bill 2024

The Chairperson of the Health Committee has re-opened for written submissions on the Misuse of Drugs (Pseudoephedrine) Amendment Bill. Please note that only written submissions are being called for at this time.
The purpose of the bill is to change the classification of pseudoephedrine as a controlled drug. The proposed amendment would allow for the sale of cold and flu medication containing pseudoephedrine in pharmacies without a prescription.
Under this legislation pseudoephedrine would be reclassified from a Class B2 to a Class C3 controlled drug under the Misuse of Drugs Act 1975. The different classes of controlled drugs are described in regulation 25(2) of the Misuse of Drugs Regulation 1977.
Tell the Health Committee what you think
Make a submission on the bill, via Parliament’s website, by 12pm on Friday 1 March 2024.